Hypersexuality Induced by Rasagiline Monotherapy in a Patinet with Parkinson's Disease.
- Author:
Hanjun KIM
1
;
Chae Won LIM
;
Il Soo KIM
;
Sun Jong PYO
;
Mi Jung KIM
;
Young Min PARK
;
Seong Beom KOH
Author Information
- Publication Type:Case Report
- Keywords: Impulse control disorders; Monoamine oxidase B inhibitors; Parkinson's disease
- MeSH: Asian Continental Ancestry Group; Caregivers; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Male; Middle Aged; Parkinson Disease*
- From:Journal of the Korean Neurological Association 2017;35(4):235-236
- CountryRepublic of Korea
- Language:Korean
- Abstract: Impulse control disorders including hypersexuality occur occasionally in Parkinson's disease, especially when treated with dopamine agonist. A 62-year-old male with Parkinson's disease was initially treated with rasagiline monotherapy and presented hypersexuality. After 8 weeks of discontinuation of the drug, his hypersexual behavior was significantly improved. To our knowledge, this is the first reported Asian case of a hypersexuality caused by rasagiline. Our observation emphasizes that patients and caregivers need to be educated on the possibility of hypersexuality resulting from rasagiline.
